Since CD133 expression has been reported to characterize CSC-like populations in many tumors, including pancreatic cancer, the effect of miR-137 on the CD133+ populations of AsPC-1 and PANC-1 cells was examined by flow cytometry and immunofluorescence. The gene discussed is PROM1; the disease is pancreatic neoplasm.